The Market for Chronic Respiratory Disease Management
The Chronic Disease Management Market for chronic respiratory diseases, such as asthma and Chronic Obstructive Pulmonary Disease (COPD), is experiencing significant growth. This is driven by the rising prevalence of these conditions and technological innovations that enable better monitoring and management. Digital spirometers and smart inhalers, for example, allow patients and doctors to track lung function and medication adherence, respectively. These tools provide real-time data that helps clinicians optimize treatment plans and intervene quickly in case of a worsening condition. The growing global burden of air pollution and smoking is expected to further increase the demand for effective respiratory disease management solutions.